MedPath

Second serosurveillance study in the Netherlands for the evaluation of the Dutch National Immunisation Programme: the PIENTER 2 study.

Completed
Conditions
Infectious Diseases, Vaccines, National Immunisation Program
Registration Number
NL-OMON23975
Lead Sponsor
ational Institute for Public Health and the Environment (RIVM)
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
7700
Inclusion Criteria

1. Subject is part of the study sample;

2. Aged 0-79 years old;

Exclusion Criteria

1 Subject is an employee of the RIVM.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath